{
    "name": "UBS EURO STOXX 50 ESG UCITS ETF",
    "type": "ETF",
    "ucits": true,
    "leverage": false,
    "derivatives": true,
    "swaps": true,
    "inverse": false,
    "replication_method": "physical",
    "complex_factors": [
        "Derivative usage for replication",
        "OTC derivatives with counterparty risk"
    ],
    "classification": "complex",
    "supporting_data": "The ETF primarily uses physical replication but explicitly mentions the use of derivatives, particularly OTC derivatives, to achieve its investment objective when direct investment is impractical. The KIID highlights counterparty risk from OTC derivatives, which is mitigated but not eliminated. While the factsheet states 'Physical (Full replicated)' as the replication methodology, the KIID reveals that derivatives are used when direct replication is not possible or practicable. This dual approach introduces complexity, especially with OTC derivatives that carry counterparty risk. The fund's risk category of 6 also indicates higher volatility and potential complexity.",
    "confidence": 85,
    "counter_argument": "The factsheet suggests a straightforward physical replication strategy, which would typically classify the ETF as non-complex. However, the KIID's explicit mention of derivative usage, including OTC derivatives with associated counterparty risks, overrides this simplicity. The use of derivatives beyond efficient portfolio management (EPM) and the presence of counterparty risk are key factors that push this into the complex category under MiFID II rules."
}